Satsuma Pharmaceuticals, Inc. Proceeds from Stock Options Exercised
Satsuma Pharmaceuticals, Inc. reported Proceeds from Stock Options Exercised of $8.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2022-05-10
- Satsuma Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2021-03-31 was $8.00K, a 27.27% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2020-09-30 was $32.00K, a 86.99% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2019 was $305.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $8.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $8.00K 10-Q · filed 2021-08-10 | ||
| 2021-03-31 | $8.00K 10-Q · filed 2022-05-10 | |||
| 2020-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $71.00K derived: sum of 2 quarters · filed 2021-11-09 | $82.00K 10-Q · filed 2021-11-09 | $88.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $50.00K 10-Q · filed 2021-08-10 | $56.00K derived: sum of 3 quarters · filed 2021-08-10 | $302.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $11.00K 10-Q · filed 2021-05-11 | $17.00K derived: sum of 2 quarters · filed 2021-05-11 | $263.00K derived: sum of 3 quarters · filed 2021-05-11 | $263.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $252.00K derived: sum of 2 quarters · filed 2020-11-10 | $252.00K derived: sum of 3 quarters · filed 2020-11-10 | $305.00K 10-K · filed 2020-03-10 |
| 2019-09-30 | $246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $246.00K derived: sum of 2 quarters · filed 2020-11-10 | $299.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $53.00K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $53.00K 10-Q · filed 2020-05-12 |